HRP20000867B1 - Pharmaceutical formulations for aerosols with two or more active substances - Google Patents

Pharmaceutical formulations for aerosols with two or more active substances

Info

Publication number
HRP20000867B1
HRP20000867B1 HR20000867A HRP20000867A HRP20000867B1 HR P20000867 B1 HRP20000867 B1 HR P20000867B1 HR 20000867 A HR20000867 A HR 20000867A HR P20000867 A HRP20000867 A HR P20000867A HR P20000867 B1 HRP20000867 B1 HR P20000867B1
Authority
HR
Croatia
Prior art keywords
active substances
aerosols
pharmaceutical formulations
propellant
salts
Prior art date
Application number
HR20000867A
Other languages
English (en)
Croatian (hr)
Inventor
Patrick Mcnamara Daniel
A. De Stefano George
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26046888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20000867(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1998127178 external-priority patent/DE19827178A1/de
Priority claimed from DE1998142963 external-priority patent/DE19842963A1/de
Application filed by Boehringer Ingelheim Pharmaceuticals Inc. filed Critical Boehringer Ingelheim Pharmaceuticals Inc.
Publication of HRP20000867A2 publication Critical patent/HRP20000867A2/hr
Publication of HRP20000867B1 publication Critical patent/HRP20000867B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20000867A 1998-06-18 2000-12-15 Pharmaceutical formulations for aerosols with two or more active substances HRP20000867B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998127178 DE19827178A1 (de) 1998-06-18 1998-06-18 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
DE1998142963 DE19842963A1 (de) 1998-09-19 1998-09-19 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
PCT/US1999/012785 WO1999065464A1 (en) 1998-06-18 1999-06-08 Pharmaceutical formulations for aerosols with two or more active substances

Publications (2)

Publication Number Publication Date
HRP20000867A2 HRP20000867A2 (en) 2001-10-31
HRP20000867B1 true HRP20000867B1 (en) 2010-10-31

Family

ID=26046888

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000867A HRP20000867B1 (en) 1998-06-18 2000-12-15 Pharmaceutical formulations for aerosols with two or more active substances

Country Status (33)

Country Link
EP (1) EP1087750B1 (sh)
JP (1) JP2003522102A (sh)
KR (1) KR100600423B1 (sh)
CN (1) CN1161104C (sh)
AR (1) AR019690A1 (sh)
AT (1) ATE253896T1 (sh)
AU (1) AU759222B2 (sh)
BG (1) BG65252B1 (sh)
BR (1) BR9911351A (sh)
CA (1) CA2335065C (sh)
CO (1) CO5070580A1 (sh)
CZ (1) CZ300910B6 (sh)
DE (1) DE69912781T2 (sh)
DK (1) DK1087750T3 (sh)
EE (1) EE04450B1 (sh)
ES (1) ES2211108T3 (sh)
HK (1) HK1037974A1 (sh)
HR (1) HRP20000867B1 (sh)
HU (1) HU229064B1 (sh)
ID (1) ID27554A (sh)
IL (2) IL140353A0 (sh)
ME (1) ME00838B (sh)
MY (1) MY121073A (sh)
NO (1) NO329416B1 (sh)
NZ (1) NZ509418A (sh)
PL (1) PL193695B1 (sh)
PT (1) PT1087750E (sh)
RS (1) RS49977B (sh)
RU (1) RU2218152C2 (sh)
SK (1) SK284756B6 (sh)
TR (1) TR200003721T2 (sh)
TW (1) TW528606B (sh)
WO (1) WO1999065464A1 (sh)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
DE60031504T2 (de) 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford Fluticasonpropionat arzneizubereitung
DE60017450T2 (de) * 1999-11-23 2006-03-02 Glaxo Group Ltd., Greenford Pharmazeutische formulierungen enthaltend salmeterol
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
JP5392880B2 (ja) 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
PT1446119E (pt) 2001-09-18 2006-07-31 Nycomed Danmark Aps Substancias que contem ipratropio e xilometazolina na sua composicao para o tratamento da constipacao comum
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
JP2008546634A (ja) * 2005-03-16 2008-12-25 ハネウェル・インターナショナル・インコーポレーテッド 医薬送達製剤、デバイス及び方法
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8061350B2 (en) 2006-06-02 2011-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process and device for dosing pharmaceutical agents
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
WO2010105776A1 (en) 2009-03-17 2010-09-23 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EA026241B1 (ru) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Распылитель
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011084316A2 (en) 2009-12-16 2011-07-14 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
BR112016023983B1 (pt) 2014-05-07 2022-10-18 Boehringer Ingelheim International Gmbh Contentor para um nebulizador, nebulizador para um fluido e método para conectar um contentor a um dispositivo indicador
US10716907B2 (en) 2014-05-07 2020-07-21 Boehringer Ingelheim International Gmbh Nebulizer
PL3139984T3 (pl) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizator
WO2020152548A1 (en) * 2019-01-24 2020-07-30 Glenmark Pharmaceuticals Limited Stable aerosol inhalation compositions of formoterol

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0499344A2 (en) * 1988-12-06 1992-08-19 Riker Laboratories, Inc. Medicinal aerosol formulations
WO1994013262A1 (en) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0499344A2 (en) * 1988-12-06 1992-08-19 Riker Laboratories, Inc. Medicinal aerosol formulations
WO1994013262A1 (en) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation

Also Published As

Publication number Publication date
CN1307470A (zh) 2001-08-08
CO5070580A1 (es) 2001-08-28
TR200003721T2 (tr) 2001-06-21
HUP0104734A3 (en) 2003-05-28
HU229064B1 (en) 2013-07-29
NO329416B1 (no) 2010-10-18
SK284756B6 (sk) 2005-11-03
AU759222B2 (en) 2003-04-10
ME00838B (me) 2008-09-29
MY121073A (en) 2005-12-30
HRP20000867A2 (en) 2001-10-31
HK1037974A1 (en) 2002-03-01
PL345685A1 (en) 2002-01-02
EP1087750A1 (en) 2001-04-04
PT1087750E (pt) 2004-02-27
YU80000A (sh) 2003-04-30
KR100600423B1 (ko) 2006-07-13
BR9911351A (pt) 2001-03-13
IL140353A0 (en) 2002-02-10
SK19392000A3 (sk) 2001-07-10
DE69912781D1 (de) 2003-12-18
NZ509418A (en) 2003-06-30
AR019690A1 (es) 2002-03-13
NO20006318D0 (no) 2000-12-12
BG105033A (en) 2001-09-28
PL193695B1 (pl) 2007-03-30
BG65252B1 (bg) 2007-10-31
EE200000759A (et) 2002-04-15
KR20010072621A (ko) 2001-07-31
DK1087750T3 (da) 2004-01-26
JP2003522102A (ja) 2003-07-22
DE69912781T2 (de) 2004-10-21
CZ20004750A3 (en) 2001-05-16
RU2218152C2 (ru) 2003-12-10
WO1999065464A1 (en) 1999-12-23
CZ300910B6 (cs) 2009-09-09
NO20006318L (no) 2001-01-30
RS49977B (sr) 2008-09-29
CN1161104C (zh) 2004-08-11
AU4552199A (en) 2000-01-05
ATE253896T1 (de) 2003-11-15
EE04450B1 (et) 2005-04-15
CA2335065A1 (en) 1999-12-23
EP1087750B1 (en) 2003-11-12
TW528606B (en) 2003-04-21
CA2335065C (en) 2008-06-03
HUP0104734A2 (hu) 2002-05-29
ES2211108T3 (es) 2004-07-01
ID27554A (id) 2001-04-12
IL140353A (en) 2006-09-05

Similar Documents

Publication Publication Date Title
HRP20000867B1 (en) Pharmaceutical formulations for aerosols with two or more active substances
BR0012013A (pt) Métodos de aerossolizar uma formulação farmacêutica, e de administrar uma formulação farmacêutica, dispositivo de aerossolização, sistema de aerossolização, e, receptáculo
RS49764B (sr) Farmaceutski preparat za primenu na mukozu
ME00333B (me) Farmaceutski aerosolni preparat
ME00220B (me) Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
DK0799024T3 (da) Farmaceutisk aerosol indeholdende mindst en sukker
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
TR200101442T2 (tr) HFA 227 ve HFA 137 ihtiva eden farmasötik aeorosol bileşimi
DE60114571D1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
YU56600A (sh) Uređaj za raznošenje aktivnog agensa u pluća pacijenta
KR900009057A (ko) 의약용 에어로졸 제제
RS49803B (sr) Primena lekovitih preparata rastvorenih u vodi za dobijanje aerosolova bez potisnog gasa
CA2353847A1 (en) Pulmonary drug delivery
DE69205177D1 (de) Pharmazeutische Aerosolformulierung.
BR9917089A (pt) Composições e métodos para distribuição mucosal
RU94022269A (ru) Состав аэрозоля, находящийся под давлением
HUP9802391A2 (hu) Inhaláló berendezés szalmeterol adagolására mért dózisban
BR9809448A (pt) Produtos aerossóis medicinais.
TNSN01003A1 (fr) Appareil d'administration d'aerosols a comptage de dose dans des propulseurs hydrofluoroalcanes.
DK1121145T3 (da) Insulinpræparater til indgivelse via lungerne, som indeholder mentol
WO2002024175A3 (en) Pharmaceutical formulation for pulmonary or nasal administration
ECSP003547A (es) Sistemas y metodos para aerosolizar formulaciones farmaceuticas

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20180524

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20190608